中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
15期
80-82
,共3页
宋静%许秀金%叶巧云%叶华琼
宋靜%許秀金%葉巧雲%葉華瓊
송정%허수금%협교운%협화경
黄芪%磷酸二果糖%小儿%病毒性心肌炎
黃芪%燐痠二果糖%小兒%病毒性心肌炎
황기%린산이과당%소인%병독성심기염
Astragalus membranaceus%Two phosphoric acid fructose%Children%Viral myocarditis
目的:探讨黄芪联合果糖二磷酸钠治疗小儿病毒性心肌炎(VMC)的疗效及安全性。方法将2013年1月~2014年6月我院VMC患儿60例随机分为观察组和对照组,对照组给予常规治疗,观察组给予黄芪联合果糖二磷酸钠治疗,评估两组治疗效果及安全性。结果观察组患儿总有效率明显高于对照组(P<0.05)。治疗后观察组患儿CK、CK-MB、LDH、cTnI明显少于对照组(P<0.05)。结论黄芪联合磷酸二果糖治疗小儿VMC的疗效确切,副作用少,值得应用。
目的:探討黃芪聯閤果糖二燐痠鈉治療小兒病毒性心肌炎(VMC)的療效及安全性。方法將2013年1月~2014年6月我院VMC患兒60例隨機分為觀察組和對照組,對照組給予常規治療,觀察組給予黃芪聯閤果糖二燐痠鈉治療,評估兩組治療效果及安全性。結果觀察組患兒總有效率明顯高于對照組(P<0.05)。治療後觀察組患兒CK、CK-MB、LDH、cTnI明顯少于對照組(P<0.05)。結論黃芪聯閤燐痠二果糖治療小兒VMC的療效確切,副作用少,值得應用。
목적:탐토황기연합과당이린산납치료소인병독성심기염(VMC)적료효급안전성。방법장2013년1월~2014년6월아원VMC환인60례수궤분위관찰조화대조조,대조조급여상규치료,관찰조급여황기연합과당이린산납치료,평고량조치료효과급안전성。결과관찰조환인총유효솔명현고우대조조(P<0.05)。치료후관찰조환인CK、CK-MB、LDH、cTnI명현소우대조조(P<0.05)。결론황기연합린산이과당치료소인VMC적료효학절,부작용소,치득응용。
Objective To explore the efficacy and safety of astragalus combined with two fructose sodium phosphate in treatment of children with viral myocarditis(VMC).MethodsFrom 2013 January – 2014 June, 60 cases of children with VMC in our hospital were randomly divided into observation group and control group, the control group was given conventional treatment, the observation group was given astragalus combined with two fructose sodium phosphate treatment, to evaluate the efficacy and safety.Results The total effect in the observation group was better than that in control group (P<0.05). After the treatment, the level of CK、CK-MB、LDH、cTnI in the observation group with was significantly less than the control group (P<0.05).Conclusion The curative effect of astragalus combined with two fructose sodium phosphate in treatment of children with viral myocarditis is good and is less side effet, so it is worth of application.